Micro-entity Accounts - AGAK BIOLOGICS LTD

Registered Number SC692595

AGAK BIOLOGICS LTD

Micro-entity Accounts

31 August 2025

AGAK BIOLOGICS LTD Registered Number SC692595

	2025	2024
	£	£
Fixed Assets	800,000	850,000
Current Assets	115,000	52,000
Creditors: amounts falling due within one year	0	0
Net current assets (liabilities)	115,000	52,000
Total assets less current liabilities	915,000	902,000
Creditors: amounts falling due after more than one year	(1,250,000)	(1,250,000)
Provisions for liabilities	(10,000)	(25,000)
Accruals and deferred income	(75,000)	(26,000)
Total net assets (liabilities)	(420,000)	(399,000)
Capital and reserves	(420,000)	(399,000)

For the year ending 31 August 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 31 December 2025

And signed on their behalf by:
Prince Agyirey-Kwakye, Director